---
$id: https://graph.org.ai/products/commodity/51112008
$type: Product
source: UNSPSC
code: "51112008"
title: "Sorafenib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sorafenib

**UNSPSC Code**: 51112008
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protein kinase inhibitor with the molecular formula C21H16ClF3N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9ZOQ3TZI87, chemically known as 2-pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl- but generally known as sorafenib, which bears US NIH Compound Identifier 216239. European Medicines Agency schedules Sorafenib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23139. The term SORAFENIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 4, 2003, List 50). World Health Organization schedules sorafenib in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule sorafenib under HS 29333999 and SITC 51574. As of Q4 2014, SORAFENIB remains the US FDA Preferred Term for this commodity. Sorafenib bears US NLM identifiers UMLS ID C1516119 and NCI Concept Code C61948. SMILES: CLC1C(CC(NC(=O)NC2CCC(OC3CC(NCC3)C(=O)NC)CC2)CC1)C(F)(F)F.

